바이오에프디엔씨 Stock: price and insider trades · South Korea

바이오에프디엔씨, classified in the Chemicals sector, is a listed company. Its insiders report their share dealings to DART (FSS). Between 1 November 2025 and 1 November 2026, 2 insiders published 4 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 4 filings, this issuer sits below that mark. Over the whole record (from 2022), the tally stands at 2 purchases and no sales.

No insider has bought 바이오에프디엔씨 shares on the open market in the past twelve months.

Elsewhere in the same sector, our signals recently picked up insider purchases at Symrise AG and Titan. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.